首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方丹参滴丸联合普萘洛尔治疗不稳定型心绞痛的临床研究
引用本文:顾玉,陈燕红,王锡惠.复方丹参滴丸联合普萘洛尔治疗不稳定型心绞痛的临床研究[J].现代药物与临床,2019,34(2):351-354.
作者姓名:顾玉  陈燕红  王锡惠
作者单位:无锡市精神卫生中心药学部,江苏无锡,214151;无锡市第三人民医院心血管内科,江苏无锡,214044
摘    要:目的探讨复方丹参滴丸联合盐酸普萘洛尔片治疗不稳定型心绞痛的临床效果。方法选取2015年2月—2017年1月无锡市第三人民医院诊治的98例不稳定型心绞痛患者为研究对象,根据数字表法将患者随机分为对照组和治疗组,每组49例。对照组口服盐酸普萘洛尔片,10 mg/次,2次/d;治疗组在对照组的基础上口服复方丹参滴丸,10丸/次,3次/d。两组均连续用药4周。观察两组患者的临床疗效和心电图疗效,同时比较治疗前后两组患者的心绞痛发作情况、心肌酶指标。结果治疗后,对照组和治疗组的总有效率分别为81.63%、95.92%,两组比较差异具有统计学意义(P0.05)。治疗后,对照组和治疗组的心电图疗效总有效率分别为71.43%、89.80%,两组比较差异具有统计学意义(P0.05)。治疗后,两组心绞痛发作次数、发作持续时间明显降低,同组治疗前后比较差异具有统计学意义(P0.05);治疗后,治疗组心绞痛发作情况明显低于对照组,两组比较差异具有统计意义(P0.05)。治疗后,两组血清心肌钙蛋白I(cTnI)、肌酸激酶同工酶(CK-MB)水平均显著降低,同组治疗前后比较差异具有统计学意义(P0.05);治疗后,治疗组心肌酶指标水平显著低于对照组,两组比较差异具有统计意义(P0.05)。结论复方丹参滴丸联合盐酸普萘洛尔片治疗不稳定型心绞痛具有较好的临床疗效,可有效改善患者症状和体征,改善心肌功能,安全性高,具有一定的临床推广应用价值。

关 键 词:复方丹参滴丸  盐酸普萘洛尔片  不稳定型心绞痛  心绞痛发作情况  心肌酶指标
收稿时间:2018/4/8 0:00:00

Clinical study on Compound Danshen Dripping Pills combined with propranolol in treatment of unstable angina pectoris
GU Yu,CHEN Yan-hong and WANG Xi-hui.Clinical study on Compound Danshen Dripping Pills combined with propranolol in treatment of unstable angina pectoris[J].Drugs & Clinic,2019,34(2):351-354.
Authors:GU Yu  CHEN Yan-hong and WANG Xi-hui
Institution:Department of Pharmacy, Wuxi Mental Health Center, Wuxi 214151, China,Department of Pharmacy, Wuxi Mental Health Center, Wuxi 214151, China and Department of Cardiovascular Medicine, Wuxi Third People''s Hospital, Wuxi 214044, China
Abstract:Objective To investigate the clinical effects of Compound Danshen Dripping Pills combined with Propranolol Hydrochloride Tablets in treatment of unstable angina pectoris. Methods Patients (98 cases) with unstable angina pectoris in Wuxi Third People''s Hospital from February 2015 to January 2017 were randomly divided into control and treatment groups, and each group had 49 cases. Patients in the control group were po administered with Propranolol Hydrochloride Tablets, 10 mg/time, twice daily. Patients in the treatment group were po administered with Compound Danshen Dripping Pills on the basis of the control group, 3 pills/time, three times daily. Patients in two groups were treated for 4 weeks. After treatment, clinical efficacy and electrocardiogram efficacy were evaluated, and the attack of angina pectoris and myocardial enzymes indexes in two groups before and after treatment were compared. Results After treatment, the clinical efficacy in the control and treatment group were 81.63% and 95.92%, and there were differences between two groups (P<0.05). After treatment, the efficacy of electrocardiogram in the control and treatment groups were 71.43% and 89.80%, respectively, and there was difference between two groups (P<0.05). After treatment, the frequency and duration of angina pectoris in two groups were significantly decreased, and the difference was statistically significant in the same group (P<0.05). After treatment, the attacks of angina pectoris in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P<0.05). After treatment, the levels of cTnI and CK-MB in two groups were significantly decreased, and the difference was statistically significant in the same group (P<0.05). After treatment, the myocardial enzymes indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P<0.05). Conclusion Compound Danshen Dripping Pills combined with Propranolol Hydrochloride Tablets has clinical curative effect in treatment of unstable angina pectoris, can effectively improve symptoms and signs, and improve cardiac muscle function, with high safety, which has a certain clinical application value.
Keywords:Compound Danshen Dripping Pills  Propranolol Hydrochloride Tablets  unstable angina pectoris  attack of angina pectoris  myocardial enzymes index
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《现代药物与临床》浏览原始摘要信息
点击此处可从《现代药物与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号